Atlas Trials

Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients

Clinical trial NCT04390984 · UNKNOWN

Trial details

NCT number
NCT04390984
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
NSCLC
Start date
2020-05-26
Primary completion
2021-02-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.